Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2458
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study ; volume:12 ; number:1 ; day:1 ; month:6 ; year:2012 ; pages:1-10 ; date:12.2012
BMC public health ; 12, Heft 1 (1.6.2012), 1-10, 12.2012
- Urheber
-
Cobiac, Linda J.
- Beteiligte Personen und Organisationen
-
Magnus, Anne
Barendregt, Jan J.
Carter, Rob
Vos, Theo
SpringerLink (Online service)
- DOI
-
10.1186/1471-2458-12-398
- URN
-
urn:nbn:de:1111-201608148913
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cobiac, Linda J.
- Magnus, Anne
- Barendregt, Jan J.
- Carter, Rob
- Vos, Theo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis
Cost-effectiveness of a community-based cardiovascular disease prevention intervention in medically underserved rural areas
Prevention of cardiovascular diseases
Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis
HIV prevention cost-effectiveness: a systematic review
Improving prevention and early diagnosis
Cardiovascular risk prevention in children
Understanding human – bat interactions in NSW, Australia: improving risk communication for prevention of Australian bat lyssavirus
YI 2.6 Comparison of Cardiovascular Disease Primary Prevention Guidelines between Australia, England and the United States
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis
Cost-effectiveness of a community-based cardiovascular disease prevention intervention in medically underserved rural areas
Prevention of cardiovascular diseases
Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis
HIV prevention cost-effectiveness: a systematic review
Improving prevention and early diagnosis
Cardiovascular risk prevention in children
Understanding human – bat interactions in NSW, Australia: improving risk communication for prevention of Australian bat lyssavirus
YI 2.6 Comparison of Cardiovascular Disease Primary Prevention Guidelines between Australia, England and the United States
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
Prevention and treatment of cardiovascular disease in Ethiopia: a cost-effectiveness analysis
Cost-effectiveness of a community-based cardiovascular disease prevention intervention in medically underserved rural areas
Prevention of cardiovascular diseases
Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis
HIV prevention cost-effectiveness: a systematic review
Improving prevention and early diagnosis
Cardiovascular risk prevention in children
Understanding human – bat interactions in NSW, Australia: improving risk communication for prevention of Australian bat lyssavirus